{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T20:46:45Z","timestamp":1764276405788},"reference-count":46,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T00:00:00Z","timestamp":1138147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Alcoholism Clin &amp;amp; Exp Res"],"published-print":{"date-parts":[[2006,2]]},"abstract":"<jats:p>This article highlights the proceedings of a symposium presented at the 28th Annual Scientific Meeting of the Research Society on Alcoholism in Santa Barbara, CA, June 27, 2005. The organizer and chair was Henry R. Kranzler. The presentations included: (1) Introduction, by Henry R. Kranzler; (2) Neurobiology of Alcohol Dependence: Implications for Medical Treatment, by George Koob; (3) Advances in Alcoholism Pharmacotherapy, by Henry R. Kranzler; (4) Patient Acceptance of Alcoholism Pharmacotherapy, by David R. Gastfriend; (5) System Challenges in the Adoption of Pharmacotherapy, by Robert M. Swift; and (6) Pharmacotherapy for Alcohol Dependence: Strengths, Challenges, and Future Directions, by Mark L. Willenbring.<\/jats:p>","DOI":"10.1111\/j.1530-0277.2006.00022.x","type":"journal-article","created":{"date-parts":[[2006,3,3]],"date-time":"2006-03-03T12:17:17Z","timestamp":1141388237000},"page":"272-281","source":"Crossref","is-referenced-by-count":13,"title":["Advances in the Pharmacotherapy of Alcoholism: Challenging Misconceptions"],"prefix":"10.1111","volume":"30","author":[{"given":"Henry R.","family":"Kranzler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Koob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Gastfriend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Swift","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark L.","family":"Willenbring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,1,25]]},"reference":[{"key":"e_1_2_9_2_1","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"issue":"1","key":"e_1_2_9_3_1","first-page":"S53","article-title":"Current pharmacotherapies of alcoholism","volume":"12","author":"Anton RF","year":"2003","journal-title":"a U S perspective"},{"key":"e_1_2_9_4_1","first-page":"486","volume-title":"Annals of the New York Academy of Sciences, Vol. 877, Advancing from the Ventral Striatum to the Extended Amygdala: Implications for Neuropsychiatry and Drug Abuse","author":"Aston\u2010Jones G","year":"1999"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300657"},{"key":"e_1_2_9_6_1","first-page":"811","article-title":"Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence","volume":"99","author":"Bouza C","year":"2004","journal-title":"a systematic review"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881103174017"},{"key":"e_1_2_9_8_1","first-page":"1107","article-title":"Testing combined pharmacotherapies and behavioral interventions in alcohol dependence","volume":"27","author":"Combine Study Research Group","year":"2003","journal-title":"rationale and methods"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ALC.0000171061.03686.BC"},{"key":"e_1_2_9_10_1","first-page":"1449","article-title":"Disulfiram treatment of alcoholism","volume":"256","author":"Fuller RK","year":"1986","journal-title":"a Veteran's Administration Cooperative Study"},{"key":"e_1_2_9_11_1","first-page":"1617","article-title":"Efficacy and tolerability of long\u2010acting injectable naltrexone for alcohol dependence","volume":"293","author":"Garbutt JC","year":"2005","journal-title":"a randomized controlled trial"},{"key":"e_1_2_9_12_1","first-page":"223","article-title":"The 12\u2010month prevalence and trends in DSM\u2010IV alcohol abuse and dependence","volume":"74","author":"Grant BF","year":"2004","journal-title":"United States, 1991\u20131992 and 2001\u20132002"},{"key":"e_1_2_9_13_1","first-page":"807","article-title":"Prevalence and co\u2010occurrence of substance use disorders and independent mood and anxiety disorders","volume":"61","author":"Grant BF","year":"2004","journal-title":"results from the national epidemiologic survey on alcohol and related conditions (NESARC)"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(97)00130-9"},{"key":"e_1_2_9_15_1","first-page":"1677","article-title":"Oral topiramate for treatment of alcohol dependence","volume":"361","author":"Johnson BA","year":"2003","journal-title":"a randomized controlled trial"},{"key":"e_1_2_9_16_1","first-page":"92","article-title":"Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism","volume":"60","author":"Kiefer F","year":"2003","journal-title":"a double-blind, placebo-controlled study"},{"key":"e_1_2_9_17_1","first-page":"232","article-title":"Alcoholism","volume":"27","author":"Koob GF","year":"2003","journal-title":"allostasis and beyond"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2903550"},{"key":"e_1_2_9_19_1","first-page":"52","article-title":"Drug abuse","volume":"278","author":"Koob GF","year":"1997","journal-title":"hedonic homeostatic dysregulation"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(00)00195-0"},{"key":"e_1_2_9_21_1","first-page":"263","volume-title":"Recent Developments in Alcoholism, Vol. 16, Research on Alcoholism Treatment","author":"Koob GF","year":"2003"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000084030.22282.6d"},{"key":"e_1_2_9_23_1","first-page":"1051","article-title":"Naltrexone depot for treatment of alcohol dependence","volume":"28","author":"Kranzler HR","year":"2004","journal-title":"a multicenter, randomized, placebo-controlled clinical trial"},{"key":"e_1_2_9_24_1","first-page":"7856","article-title":"Additive effect of stress and drug cues on reinstatement of ethanol seeking","volume":"22","author":"Liu X","year":"2002","journal-title":"exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms"},{"key":"e_1_2_9_25_1","first-page":"485","article-title":"Pharmacotherapy of alcohol dependence","volume":"18","author":"Mann K","year":"2004","journal-title":"a review of the clinical data"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2003.tb00543.x"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00377.x"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa022615"},{"key":"e_1_2_9_29_1","first-page":"764","article-title":"Contemporary addiction treatment","volume":"56","author":"McLellan AT","year":"2004","journal-title":"a review of systems problems for adults and adolescents"},{"key":"e_1_2_9_30_1","first-page":"403","article-title":"Prospects for a rational pharmacotherapy of alcoholism","volume":"50","author":"Meyer R","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-1934-2_15"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.15288\/jsa.2001.62.211"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.10.1238"},{"key":"e_1_2_9_34_1","first-page":"783","article-title":"Intra\u2010BNST acamprosate attenuates withdrawal\u2010induced increases in ethanol consumption in dependents rats","volume":"28","author":"Morse AC","year":"2002","journal-title":"Society Neurosci Abstr"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/35053570"},{"key":"e_1_2_9_36_1","first-page":"881","article-title":"Naltrexone and coping skills therapy for alcohol dependence","volume":"49","author":"O'Malley SS","year":"1992","journal-title":"a controlled study"},{"key":"e_1_2_9_37_1","first-page":"359","article-title":"Pathophysiological basis of vulnerability to drug abuse","volume":"36","author":"Piazza PV","year":"1996","journal-title":"role of an interaction between stress, glucocorticoids, and dopaminergic neurons"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1037\/0278-6133.13.1.39"},{"key":"e_1_2_9_39_1","first-page":"134","article-title":"Alcoholics Anonymous and the use of medications to prevent relapse","volume":"61","author":"Rychtarik RG","year":"2000","journal-title":"an anonymous survey of member attitudes"},{"key":"e_1_2_9_40_1","first-page":"13","article-title":"Stress\u2010induced relapse to heroin and cocaine seeking in rats","volume":"33","author":"Shaham Y","year":"2000","journal-title":"a review"},{"key":"e_1_2_9_41_1","first-page":"1381","volume-title":"Neuropsychopharmacology: the Fifth Generation of Progress","author":"Shippenberg TS","year":"2002"},{"key":"e_1_2_9_42_1","first-page":"39","article-title":"Acamprosate and alcohol","volume":"305","author":"Spanagel R","year":"1996","journal-title":"I. Effects on alcohol intake following alcohol deprivation in the rat"},{"key":"e_1_2_9_43_1","first-page":"45","article-title":"Acamprosate and alcohol","volume":"305","author":"Spanagel R","year":"1996","journal-title":"II. Effects on alcohol withdrawal in the rat"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1300\/J069v17n03_04"},{"key":"e_1_2_9_45_1","first-page":"1","article-title":"Research to practice","volume":"24","author":"Thomas C","year":"2003","journal-title":"adoption of naltrexone in alcoholism treatment"},{"key":"e_1_2_9_46_1","first-page":"1494","article-title":"Increased ethanol self\u2010administration and anxiety\u2010like behavior during acute withdrawal and protracted abstinence","volume":"26","author":"Valdez GR","year":"2002","journal-title":"regulation by corticotropin-releasing factor"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1992.01820110040006"}],"container-title":["Alcoholism: Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1530-0277.2006.00022.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1530-0277.2006.00022.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T19:02:03Z","timestamp":1697396523000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1530-0277.2006.00022.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,25]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["10.1111\/j.1530-0277.2006.00022.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1530-0277.2006.00022.x","archive":["Portico"],"relation":{},"ISSN":["0145-6008","1530-0277"],"issn-type":[{"value":"0145-6008","type":"print"},{"value":"1530-0277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,25]]}}}